FDA Investigator Camille D Brown
Camille D Brown has inspections in 12 countries as of 04 Nov 2022. Camille D Brown has collaborated with a combined 1877 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
100
Last Inspection Date:
04 Nov 2022
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
India,
Spain,
Poland,
France,
Hungary,
Jordan,
Italy,
Canada,
Australia,
South Africa
Co-Investigator(s):
Adam C Hipko,
Adrian Rodriguez,
Alanna Lmussawwir Bias,
Amanda J White,
Andrace Lde Yampert,
Andrea A Branche,
Angela Mock,
Arie R Dyk,
Bing Lin,
Brackens Harris,
Brandi E Williams,
Charles D Brown,
Christopher D Rush,
Christopher J Smith,
Connie L Hannon Rabel,
Corrine M Carter,
Crystal S Harris Smith,
Cynthia A Harris, MD, RN,
Dallas E Gilbreath Jr,
Daniel S Fam,
Danny D Horner,
Darla J Christopher,
Deborah A Greco,
Denise Connelly,
Denise L Burosh,
Elisa M Fleming,
Ellen J Tave,
Elmina E Akwo,
Elvia J Cervantes,
Fernando C Martinez,
Gajendiran Mahadevan, PhD,
Gatica,
Gene R Gunn,
Glasgow,
Grant,
Iris C Macinnes,
Jacob W Reynolds,
James H Robinson,
Jamie M Bumpas,
Jane M Broussard,
Janet B Abt,
Janete F Guardia,
Janice M Hickok,
Jeffrey R Wooley,
Jennifer C Adams,
Jennifer D Young,
Jennifer Owens Dowdy,
Joanne M Schlossin,
Joel D Martinez,
Johann M Fitch,
Johnson,
Jonathan A Womack,
Joy L Ramsey,
Keegan B Mixon,
Kelly D Sheppard,
Kelly J Pegg,
Kenitra D Hewitt,
Kip J Hanks,
Kirsten S Tharp,
Lauren E Skokan,
Leighton K Ngai,
Lisa R Jennings,
Liza L Quiles,
Lloyd D Payne,
Lorie S Hannappel,
Lourdes R Genera,
Maira P Brading,
Makini Cobourne Duval, PhD,
Marc R Dickens,
Marilyn S Babu,
Mario Seminara,
Mathew T Thomas, MD,
Monique Rac Lester,
Monique S Frazier,
Myra K Casey,
Nancy A Bellamy,
Nicola M Fenty Stewart,
Patrice S Hall,
Patrick D Stone, MS,
Paul E Frazier,
Pauline N Logan,
Payne,
Peter R Lenahan,
Phillip D Waldron,
Rebecca C O Bryan,
Rebecca T Davis,
Rene R Ramirez,
Rhonda L Dash,
Rian L Pope,
Robert T Lorenz,
Ronald L Koller,
Ronda R Loyd Jones,
Ruben C Ayala, PharmD,
Sam H Haidar, PhD,
Scott B Laufenberg,
Scott T Ballard,
Shannon A Lowe,
Sherri J Jackson,
Shirley H Isbill,
State Agency,
Tamera H Hunt,
Tawny L Colling,
Toby Vern H Hill,
Travis M Beard,
Travis S Brown,
Tricia S Martinez,
William S Vitale,
Yaw O Osei,
Yoonyc,
Young M Yoon
Camille D Brown's Documents
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more